These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 2751696)

  • 1. Inhibition by methotrexate of the stable incorporation of 5-fluorouracil into murine bone marrow DNA.
    Sawyer RC; Stolfi RL; Martin DS; Balis ME
    Biochem Pharmacol; 1989 Jul; 38(14):2305-11. PubMed ID: 2751696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The selectivity of action of methotrexate in combination with 5-fluorouracil in xenografts of human colon adenocarcinomas.
    Houghton JA; Tice AJ; Houghton PJ
    Mol Pharmacol; 1982 Nov; 22(3):771-8. PubMed ID: 7155134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of L-histidinol on the metabolism of 5-fluorouracil in the BALB/c x DBA/8 F1 murine tumor system.
    Sawyer RC; Stolfi RL; Martin DS
    Cancer Res; 1988 Dec; 48(23):6664-8. PubMed ID: 2460227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incorporation of 5-fluorouracil into murine bone marrow DNA in vivo.
    Sawyer RC; Stolfi RL; Martin DS; Spiegelman S
    Cancer Res; 1984 May; 44(5):1847-51. PubMed ID: 6713387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of methotrexate pretreatment on 5-fluorouracil metabolism in L1210 cells.
    Cadman E; Heimer R; Benz C
    J Biol Chem; 1981 Feb; 256(4):1695-704. PubMed ID: 6161926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of murine tumor thymidine kinase activity in vivo following 5-fluorouracil (FUra) treatment by incorporation of FUra into RNA.
    Nord LD; Martin DS
    Biochem Pharmacol; 1991 Nov; 42(12):2369-75. PubMed ID: 1722409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thymidine enhancement of methotrexate and 5-fluorouracil toxicity in cultured human colon carcinoma.
    Benz C; Choti M; Newcomer L; Cadman E
    Cancer Chemother Pharmacol; 1984; 12(2):104-10. PubMed ID: 6199130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of 5-fluorouracil metabolism and cytotoxicity by antimetabolite pretreatment in human colorectal adenocarcinoma HCT-8.
    Benz C; Cadman E
    Cancer Res; 1981 Mar; 41(3):994-9. PubMed ID: 7459888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intratumoral injection of thymidine: enhancement of the antitumor activity and incorporation of 5-fluorouracil into tumor RNA in a murine tumor system.
    Matsuoka H; Masuda H; Maehara Y; Sugimachi K; Inokuchi K
    Cancer Treat Rep; 1986 Jul; 70(7):851-7. PubMed ID: 3719577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA repair following incorporation of 5-fluorouracil into DNA of mouse bone marrow cells.
    Schuetz JD; Wallace HJ; Diasio RB
    Cancer Chemother Pharmacol; 1988; 21(3):208-10. PubMed ID: 3359556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 5-Fluorouracil incorporation into DNA of CF-1 mouse bone marrow cells as a possible mechanism of toxicity.
    Schuetz JD; Wallace HJ; Diasio RB
    Cancer Res; 1984 Apr; 44(4):1358-63. PubMed ID: 6704957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo monitoring of changes in 5-fluorouracil metabolism induced by methotrexate measured by 19F NMR spectroscopy.
    Koutcher JA; Sawyer RC; Kornblith AB; Stolfi RL; Martin DS; Devitt ML; Cowburn D; Young CW
    Magn Reson Med; 1991 May; 19(1):113-23. PubMed ID: 2046526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of enhanced cytotoxicity of cultured L1210 cells using folinic acid in combination with sequential methotrexate and fluorouracil.
    Danhauser LL; Heimer R; Cadman E
    Cancer Chemother Pharmacol; 1985; 15(3):214-9. PubMed ID: 3876889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement by uridine of the anabolism of 5-fluorouracil in mouse T-lymphoma (S-49) cells.
    Parker WB; Klubes P
    Cancer Res; 1985 Sep; 45(9):4249-56. PubMed ID: 2411399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sequential methotrexate and 5-fluorouracil: mechanisms of synergy.
    Bertino JR; Mini E; Fernandes DJ
    Semin Oncol; 1983 Jun; 10(2 Suppl 2):2-5. PubMed ID: 6867754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elucidation of pathways of 5-fluorouracil metabolism in xenografts of human colorectal adenocarcinoma.
    Houghton JA; Houghton PJ
    Eur J Cancer Clin Oncol; 1983 Jun; 19(6):807-15. PubMed ID: 6191988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor-selective metabolism of 5-fluoro-2'-deoxycytidine coadministered with tetrahydrouridine compared to 5-fluorouracil in mice bearing Lewis lung carcinoma.
    Boothman DA; Briggle TV; Greer S
    Cancer Res; 1987 May; 47(9):2354-62. PubMed ID: 2952263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of 5-fluorouracil on DNA chain elongation in intact bone marrow cells.
    Schuetz JD; Diasio RB
    Biochem Biophys Res Commun; 1985 Nov; 133(1):361-7. PubMed ID: 4074377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The metabolism of high-molecular-weight substances in cells and the effect of anticancer drugs].
    Kanamaru R; Kakuta H; Sato T; Ishioka C; Konishi Y; Wakui A; Dei T
    Gan To Kagaku Ryoho; 1987 Mar; 14(3 Pt 2):837-44. PubMed ID: 3566294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective activation of 5'-deoxy-5-fluorouridine by tumor cells as a basis for an improved therapeutic index.
    Armstrong RD; Diasio RB
    Cancer Res; 1981 Dec; 41(12 Pt 1):4891-4. PubMed ID: 6171343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.